Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M25,910Revenue $M9,023Net Margin (%)9.4Altman Z-Score2.3
Enterprise Value $M31,739EPS $1.8Operating Margin %15.0Piotroski F-Score7
P/E(ttm)29.3Beneish M-Score-2.0Pre-tax Margin (%)10.1Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %12.4Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %8.3Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow40.2y-y EBITDA Growth Rate %-2.9ROA % (ttm)3.4Higher Current Ratio y-yY
Dividend Yield %--PEG3.5ROE % (ttm)9.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M492ROIC % (ttm)6.6Gross Margin Increase y-yY

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 51.396%Add 4.26%24,253,075
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 51.396%Reduce -60.67%26,450
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 51.39-8%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 51.39-8%Add 46.38%23,262,875
MYLJohn Keeley 2015-09-30 Add0.02%$39.8 - $71.49
($55.75)
$ 51.39-8%Add 51.47%56,120
MYLMario Gabelli 2015-09-30 Add0.01%$39.8 - $71.49
($55.75)
$ 51.39-8%Add 102.26%67,250
MYLJohn Paulson 2015-06-30 Add2.24%$57.94 - $76.06
($70.49)
$ 51.39-27%Add 46.59%21,913,061
MYLDavid Tepper 2015-06-30 Buy 1.66%$57.94 - $76.06
($70.49)
$ 51.39-27%New holding989,528
MYLFirst Eagle Investment 2015-06-30 Sold Out -0.08%$57.94 - $76.06
($70.49)
$ 51.39-27%Sold Out0
MYLJohn Keeley 2015-06-30 Buy 0.06%$57.94 - $76.06
($70.49)
$ 51.39-27%New holding37,050
MYLJoel Greenblatt 2015-06-30 Sold Out -0.01%$57.94 - $76.06
($70.49)
$ 51.39-27%Sold Out0
MYLMario Gabelli 2015-06-30 Add0.01%$57.94 - $76.06
($70.49)
$ 51.39-27%Add 232.50%33,250
MYLJoel Greenblatt 2015-03-31 Reduce-0.3%$52.74 - $64.96
($57.01)
$ 51.39-10%Reduce -97.62%16,021
MYLVanguard Health Care Fund 2015-03-31 Add0.11%$52.74 - $64.96
($57.01)
$ 51.39-10%Add 5.68%15,891,898
MYLFirst Eagle Investment 2015-03-31 Reduce-0.04%$52.74 - $64.96
($57.01)
$ 51.39-10%Reduce -30.38%586,016
MYLJohn Paulson 2014-12-31 Add0.72%$46.5 - $58.62
($53.92)
$ 51.39-5%Add 19.64%14,948,400
MYLJoel Greenblatt 2014-12-31 Buy 0.31%$46.5 - $58.62
($53.92)
$ 51.39-5%New holding673,287
MYLVanguard Health Care Fund 2014-12-31 Reduce-0.05%$46.5 - $58.62
($53.83)
$ 51.39-5%Reduce -2.64%15,037,080
MYLFirst Eagle Investment 2014-12-31 Add$46.5 - $58.62
($53.83)
$ 51.39-5%Add 3.97%841,779
MYLVanguard Health Care Fund 2014-09-30 Add1.24%$44.97 - $52.34
($48.56)
$ 51.396%Add 223.41%15,444,880
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SHEEHAN JOHN DEVP and CFO 2015-12-17Sell34,579$55.03-6.61view
HIGGINS MELINA EDirector 2015-06-15Sell8,351$73.08-29.68view
Cindrich Robert JDirector 2015-02-03Sell40,645$53.15-3.31view
CAMERON WENDYDirector 2015-02-03Sell106,551$53.15-3.31view
COURY ROBERT JExecutive Chairman 2015-02-03Sell947,119$52.55-2.21view
Malik RajivPresident 2015-02-03Sell285,394$53.15-3.31view
MAROON JOSEPH C MDDirector 2015-02-03Sell136,551$53.15-3.31view
BRESCH HEATHER MCEO 2015-02-03Sell411,996$53.15-3.31view
DIMICK NEIL FDirector 2015-02-03Sell19,781$53.15-3.31view
Mauro AnthonyPresident, North America 2015-02-03Sell13,255$53.15-3.31view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

    News about MYL:

    Articles On GuruFocus.com
    Keeley Funds Comments on Mylan N.V. Feb 03 2016 
    KEELEY All Cap Value Fund Commentary - 4th Quarter 2015 Feb 03 2016 
    David Einhorn Comments on Mylan Jan 19 2016 
    Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
    Health Care Investor Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
    John Paulson Keeps Gold, Buys Drug Manufacturers Nov 17 2015 
    Vanguard Raises Stakes in Biogen, Mylan, Merck Nov 15 2015 
    Keeley Funds Comments on Mylan NV Nov 03 2015 
    Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer Nov 02 2015 
    Alan Fournier Sells Nine Stakes in Second Quarter Sep 12 2015 

    More From Other Websites
    The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, United Therapeutics and INSYS... Feb 03 2016
    4 Top-Ranked Biotech Stocks on Sale Feb 02 2016
    Stock Watchout on Drugs - Generic -- Mylan, Neurocrine Biosciences, Horizon Pharma, and Zoetis Feb 02 2016
    Mylan’s PE Ratio of 10.1x Is Lower Than Its Peer Ratios Feb 01 2016
    [$$] Barron's 2016 Roundtable, Part 3: 12 Stock Picks Jan 30 2016
    The Majority of Brokers Recommend a “Buy” for Mylan Jan 28 2016
    Analysts Expect Mylan’s Growth to Be at 29.7% for 4Q15 Jan 28 2016
    Mylan NV breached its 50 day moving average in a Bullish Manner : January 25, 2016 Jan 25 2016
    [$$] Part 2 of the Barron's 2016 Roundtable: 31 Savvy Investment Ideas Jan 23 2016
    Mylan to Report Fourth Quarter and Full Year 2015 Financial Results on Feb. 10, 2016 Jan 21 2016
    David Einhorn Feels Mylan's Pain Jan 20 2016
    David Einhorn and the Terrible, Horrible, No Good, Very Bad 2015 Jan 20 2016
    David Einhorn's New Long Position In Mylan Jan 19 2016
    Highlights From Greenlight’s Q4 Letter: Micron Is Out & Two New Positions Jan 19 2016
    A Look Into David Einhorn's Q4 Letter To Greenlight Investors Jan 19 2016
    Mylan Launches Generic Felbatol® Tablets Jan 19 2016
    Mylan CEO: Don’t think the answer is price controls on drugs Jan 12 2016
    Goldman's top 25 Tactical Option Trades ahead of Earnings Jan 12 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK